XNAS 04 May, 2026 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 431.94 per share. | 06 Mar 2026 | 491 | 452,213 (2%) | 0% | 431.9 | 212,083 | Common Stock |
| William John Sibold | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 18,743 | 18,743 | - | - | Stock Option (Right to Buy) | |
| William John Sibold | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 431.94 per share. | 04 Mar 2026 | 1,663 | 161,829 (1%) | 0% | 431.9 | 718,316 | Common Stock |
| William John Sibold | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 14,995 | 163,492 (1%) | 0% | 0 | Common Stock | |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 431.94 per share. | 04 Mar 2026 | 646 | 13,826 (0%) | 0% | 431.9 | 279,033 | Common Stock |
| Mardi C. Dier | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 5,215 | 14,472 (0%) | 0% | 0 | Common Stock | |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 429.58 per share. | 04 Mar 2026 | 40 | 13,086 (0%) | 0% | 429.6 | 17,183 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 428.99 per share. | 04 Mar 2026 | 160 | 13,126 (0%) | 0% | 429.0 | 68,639 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 427.85 per share. | 04 Mar 2026 | 80 | 13,286 (0%) | 0% | 427.9 | 34,228 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 426.86 per share. | 04 Mar 2026 | 420 | 13,366 (0%) | 0% | 426.9 | 179,283 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 425.08 per share. | 04 Mar 2026 | 40 | 13,786 (0%) | 0% | 425.1 | 17,003 | Common Stock |
| Mardi C. Dier | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 6,519 | 6,519 | - | - | Stock Option (Right to Buy) | |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 437.65 per share. | 04 Mar 2026 | 40 | 12,490 (0%) | 0% | 437.7 | 17,506 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 436.69 per share. | 04 Mar 2026 | 80 | 12,530 (0%) | 0% | 436.7 | 34,935 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 435.31 per share. | 04 Mar 2026 | 80 | 12,610 (0%) | 0% | 435.3 | 34,825 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 434.20 per share. | 04 Mar 2026 | 160 | 12,690 (0%) | 0% | 434.2 | 69,472 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 432.55 per share. | 04 Mar 2026 | 116 | 12,850 (0%) | 0% | 432.6 | 50,176 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 430.90 per share. | 04 Mar 2026 | 120 | 12,966 (0%) | 0% | 430.9 | 51,708 | Common Stock |
| David Soergel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 4,374 | 11,919 (0%) | 0% | 0 | Common Stock | |
| David Soergel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 5,467 | 5,467 | - | - | Stock Option (Right to Buy) | |
| Carole Huntsman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 4,986 | 4,986 | - | - | Stock Option (Right to Buy) | |
| Carole Huntsman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 3,989 | 13,111 (0%) | 0% | 0 | Common Stock | |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 431.94 per share. | 04 Mar 2026 | 419 | 12,692 (0%) | 0% | 431.9 | 180,983 | Common Stock |
| Shannon T. Kelley | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 5,022 | 5,022 | - | - | Stock Option (Right to Buy) | |
| Shannon T. Kelley | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 4,017 | 12,498 (0%) | 0% | 0 | Common Stock | |
| Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 431.94 per share. | 04 Mar 2026 | 360 | 12,138 (0%) | 0% | 431.9 | 155,498 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 427.21 per share. | 02 Mar 2026 | 1,183 | 9,257 (0%) | 0% | 427.2 | 505,389 | Common Stock |
| Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.36 per share. | 23 Feb 2026 | 2,500 | 27,697 (0%) | 0% | 7.4 | 18,400 | Common Stock |
| Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2026 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 492.42 per share. | 26 Jan 2026 | 647 | 452,704 (2%) | 0% | 492.4 | 318,596 | Common Stock |
| Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.46 per share. | 26 Jan 2026 | 4,000 | 25,197 (0%) | 0% | 16.5 | 65,840 | Common Stock |
| Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2026 | 4,000 | 0 | - | - | Stock Option (Right to Buy) | |
| William John Sibold | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 492.42 per share. | 26 Jan 2026 | 1,577 | 148,497 (0%) | 0% | 492.4 | 776,546 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 494.59 per share. | 26 Jan 2026 | 570 | 9,122 (0%) | 0% | 494.6 | 281,916 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 492.42 per share. | 26 Jan 2026 | 340 | 9,692 (0%) | 0% | 492.4 | 167,423 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 490.77 per share. | 20 Jan 2026 | 2,238 | 453,351 (2%) | 0% | 490.8 | 1,098,343 | Common Stock |
| Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 501.40 per share. | 20 Jan 2026 | 429 | 8,481 (0%) | 0% | 501.4 | 215,101 | Common Stock |
| Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 490.77 per share. | 20 Jan 2026 | 263 | 8,910 (0%) | 0% | 490.8 | 129,073 | Common Stock |
| Rita Thakkar | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 2,398 | 2,398 (0%) | 0% | 0 | Common Stock | |
| Rita Thakkar | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 1,826 | 1,826 | - | - | Stock Option (Right to Buy) | |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.80 per share. | 09 Jan 2026 | 280 | 187,444 (1%) | 0% | 15.8 | 4,424 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 551.24 per share. | 09 Jan 2026 | 280 | 187,164 (1%) | 0% | 551.2 | 154,348 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 280 | 0 | - | - | Stock Option (Right to Buy) | |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.80 per share. | 09 Jan 2026 | 24,520 | 211,684 (1%) | 0% | 15.8 | 387,416 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 511.98 per share. | 09 Jan 2026 | 1,480 | 210,204 (1%) | 0% | 512.0 | 757,727 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 513.11 per share. | 09 Jan 2026 | 1,094 | 209,110 (1%) | 0% | 513.1 | 561,340 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 514.68 per share. | 09 Jan 2026 | 1,345 | 207,765 (1%) | 0% | 514.7 | 692,246 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 515.81 per share. | 09 Jan 2026 | 1,996 | 205,769 (1%) | 0% | 515.8 | 1,029,561 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 516.84 per share. | 09 Jan 2026 | 766 | 205,003 (1%) | 0% | 516.8 | 395,896 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 517.86 per share. | 09 Jan 2026 | 2,450 | 202,553 (1%) | 0% | 517.9 | 1,268,755 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 518.68 per share. | 09 Jan 2026 | 1,363 | 201,190 (1%) | 0% | 518.7 | 706,966 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 519.88 per share. | 09 Jan 2026 | 846 | 200,344 (1%) | 0% | 519.9 | 439,822 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 521.03 per share. | 09 Jan 2026 | 681 | 199,663 (1%) | 0% | 521.0 | 354,823 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 521.98 per share. | 09 Jan 2026 | 840 | 198,823 (1%) | 0% | 522.0 | 438,461 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 523.00 per share. | 09 Jan 2026 | 970 | 197,853 (1%) | 0% | 523.0 | 507,307 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 524.10 per share. | 09 Jan 2026 | 1,199 | 196,654 (1%) | 0% | 524.1 | 628,394 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 525.05 per share. | 09 Jan 2026 | 2,432 | 194,222 (1%) | 0% | 525.0 | 1,276,916 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 526.00 per share. | 09 Jan 2026 | 1,066 | 193,156 (1%) | 0% | 526.0 | 560,717 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 526.97 per share. | 09 Jan 2026 | 1,560 | 191,596 (1%) | 0% | 527.0 | 822,071 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 528.18 per share. | 09 Jan 2026 | 575 | 191,021 (1%) | 0% | 528.2 | 303,702 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 529.16 per share. | 09 Jan 2026 | 691 | 190,330 (1%) | 0% | 529.2 | 365,653 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 529.77 per share. | 09 Jan 2026 | 166 | 190,164 (1%) | 0% | 529.8 | 87,941 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 530.69 per share. | 09 Jan 2026 | 280 | 189,884 (1%) | 0% | 530.7 | 148,592 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 532.50 per share. | 09 Jan 2026 | 80 | 189,804 (1%) | 0% | 532.5 | 42,600 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 534.16 per share. | 09 Jan 2026 | 332 | 189,472 (1%) | 0% | 534.2 | 177,342 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 535.29 per share. | 09 Jan 2026 | 148 | 189,324 (1%) | 0% | 535.3 | 79,223 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 536.02 per share. | 09 Jan 2026 | 473 | 188,851 (1%) | 0% | 536.0 | 253,538 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 536.88 per share. | 09 Jan 2026 | 487 | 188,364 (1%) | 0% | 536.9 | 261,459 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 537.85 per share. | 09 Jan 2026 | 80 | 188,284 (1%) | 0% | 537.9 | 43,028 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 539.23 per share. | 09 Jan 2026 | 480 | 187,804 (1%) | 0% | 539.2 | 258,831 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 540.36 per share. | 09 Jan 2026 | 600 | 187,204 (1%) | 0% | 540.4 | 324,215 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 545.80 per share. | 09 Jan 2026 | 40 | 187,164 (1%) | 0% | 545.8 | 21,832 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 24,520 | 280 | - | - | Stock Option (Right to Buy) | |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.80 per share. | 09 Jan 2026 | 18,410 | 473,999 (3%) | 0% | 15.8 | 290,878 | Common Stock |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 240 | 0 | - | - | Stock Option (Right to Buy) | |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 512.02 per share. | 09 Jan 2026 | 960 | 473,039 (3%) | 0% | 512.0 | 491,537 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 513.12 per share. | 09 Jan 2026 | 960 | 472,079 (3%) | 0% | 513.1 | 492,595 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 514.63 per share. | 09 Jan 2026 | 937 | 471,142 (3%) | 0% | 514.6 | 482,207 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 515.82 per share. | 09 Jan 2026 | 1,578 | 469,564 (3%) | 0% | 515.8 | 813,968 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 516.81 per share. | 09 Jan 2026 | 521 | 469,043 (3%) | 0% | 516.8 | 269,257 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 517.84 per share. | 09 Jan 2026 | 2,044 | 466,999 (3%) | 0% | 517.8 | 1,058,468 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 518.67 per share. | 09 Jan 2026 | 970 | 466,029 (3%) | 0% | 518.7 | 503,106 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 519.89 per share. | 09 Jan 2026 | 539 | 465,490 (3%) | 0% | 519.9 | 280,220 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 521.11 per share. | 09 Jan 2026 | 440 | 465,050 (3%) | 0% | 521.1 | 229,289 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 521.95 per share. | 09 Jan 2026 | 588 | 464,462 (3%) | 0% | 522.0 | 306,909 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 522.98 per share. | 09 Jan 2026 | 732 | 463,730 (3%) | 0% | 523.0 | 382,823 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 524.06 per share. | 09 Jan 2026 | 1,335 | 462,395 (2%) | 0% | 524.1 | 699,623 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 525.12 per share. | 09 Jan 2026 | 1,489 | 460,906 (2%) | 0% | 525.1 | 781,903 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 526.05 per share. | 09 Jan 2026 | 913 | 459,993 (2%) | 0% | 526.0 | 480,281 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 526.95 per share. | 09 Jan 2026 | 1,135 | 458,858 (2%) | 0% | 527.0 | 598,091 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 528.16 per share. | 09 Jan 2026 | 465 | 458,393 (2%) | 0% | 528.2 | 245,593 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 529.28 per share. | 09 Jan 2026 | 554 | 457,839 (2%) | 0% | 529.3 | 293,222 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 530.45 per share. | 09 Jan 2026 | 256 | 457,583 (2%) | 0% | 530.5 | 135,796 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 531.07 per share. | 09 Jan 2026 | 30 | 457,553 (2%) | 0% | 531.1 | 15,932 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 532.50 per share. | 09 Jan 2026 | 40 | 457,513 (2%) | 0% | 532.5 | 21,300 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 534.17 per share. | 09 Jan 2026 | 271 | 457,242 (2%) | 0% | 534.2 | 144,761 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 534.93 per share. | 09 Jan 2026 | 89 | 457,153 (2%) | 0% | 534.9 | 47,609 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 535.80 per share. | 09 Jan 2026 | 299 | 456,854 (2%) | 0% | 535.8 | 160,205 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 536.88 per share. | 09 Jan 2026 | 385 | 456,469 (2%) | 0% | 536.9 | 206,700 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 537.85 per share. | 09 Jan 2026 | 40 | 456,429 (2%) | 0% | 537.9 | 21,514 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 539.26 per share. | 09 Jan 2026 | 400 | 456,029 (2%) | 0% | 539.3 | 215,706 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 540.25 per share. | 09 Jan 2026 | 40 | 455,989 (2%) | 0% | 540.3 | 21,610 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 542.72 per share. | 09 Jan 2026 | 400 | 455,589 (2%) | 0% | 542.7 | 217,088 | Common Stock |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 18,410 | 240 | - | - | Stock Option (Right to Buy) | |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.80 per share. | 09 Jan 2026 | 240 | 455,829 (2%) | 0% | 15.8 | 3,792 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 545.80 per share. | 09 Jan 2026 | 40 | 455,789 (2%) | 0% | 545.8 | 21,832 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 551.24 per share. | 09 Jan 2026 | 200 | 455,589 (2%) | 0% | 551.2 | 110,248 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2025 | 24,800 | 24,800 | - | - | Stock Option (Right to Buy) | |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 555.39 per share. | 10 Dec 2025 | 160 | 187,164 (1%) | 0% | 555.4 | 88,862 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 555.00 per share. | 10 Dec 2025 | 1,029 | 187,324 (1%) | 0% | 555.0 | 571,091 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 553.83 per share. | 10 Dec 2025 | 5,001 | 188,353 (1%) | 0% | 553.8 | 2,769,728 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 552.74 per share. | 10 Dec 2025 | 5,533 | 193,354 (1%) | 0% | 552.7 | 3,058,332 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 551.67 per share. | 10 Dec 2025 | 7,193 | 198,887 (1%) | 0% | 551.7 | 3,968,129 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 550.93 per share. | 10 Dec 2025 | 4,316 | 206,080 (1%) | 0% | 550.9 | 2,377,826 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 549.99 per share. | 10 Dec 2025 | 409 | 210,396 (1%) | 0% | 550.0 | 224,945 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 548.51 per share. | 10 Dec 2025 | 535 | 210,805 (1%) | 0% | 548.5 | 293,451 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 547.75 per share. | 10 Dec 2025 | 624 | 211,340 (1%) | 0% | 547.7 | 341,794 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.80 per share. | 10 Dec 2025 | 24,800 | 211,964 (1%) | 0% | 15.8 | 391,840 | Common Stock |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.80 per share. | 10 Dec 2025 | 18,650 | 479,694 (3%) | 0% | 15.8 | 294,670 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 547.76 per share. | 10 Dec 2025 | 491 | 479,203 (3%) | 0% | 547.8 | 268,949 | Common Stock |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2025 | 18,650 | 18,650 | - | - | Stock Option (Right to Buy) | |
| Rebecca A. Taub | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Dec 2025 | 5,455 | 455,589 (2%) | 0% | 0 | Common Stock | |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 555.39 per share. | 10 Dec 2025 | 200 | 461,044 (2%) | 0% | 555.4 | 111,078 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 554.84 per share. | 10 Dec 2025 | 1,027 | 461,244 (2%) | 0% | 554.8 | 569,822 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 553.88 per share. | 10 Dec 2025 | 3,087 | 462,271 (2%) | 0% | 553.9 | 1,709,826 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 552.81 per share. | 10 Dec 2025 | 3,857 | 465,358 (3%) | 0% | 552.8 | 2,132,197 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 551.85 per share. | 10 Dec 2025 | 4,410 | 469,215 (3%) | 0% | 551.8 | 2,433,641 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 550.99 per share. | 10 Dec 2025 | 4,723 | 473,625 (3%) | 0% | 551.0 | 2,602,307 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 550.07 per share. | 10 Dec 2025 | 486 | 478,348 (3%) | 0% | 550.1 | 267,335 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 548.56 per share. | 10 Dec 2025 | 369 | 478,834 (3%) | 0% | 548.6 | 202,418 | Common Stock |
| William John Sibold | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2025 | 50,000 | 152,474 (0%) | 0% | - | Common Stock | |
| William John Sibold | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2025 | 50,000 | 0 | - | - | Performance Restricted Stock Units | |
| William John Sibold | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 575.34 per share. | 03 Dec 2025 | 2,400 | 150,074 (0%) | 0% | 575.3 | 1,380,816 | Common Stock |
| Mardi C. Dier | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 251.63 per share. | 02 Dec 2025 | 4,173 | 14,613 (0%) | 0% | 251.6 | 1,050,052 | Common Stock |
| Mardi C. Dier | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2025 | 4,173 | 9,180 | - | - | Stock Option (Right to Buy) | |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 596.19 per share. | 02 Dec 2025 | 80 | 10,440 (0%) | 0% | 596.2 | 47,695 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 595.20 per share. | 02 Dec 2025 | 74 | 10,520 (0%) | 0% | 595.2 | 44,045 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 590.38 per share. | 02 Dec 2025 | 160 | 10,594 (0%) | 0% | 590.4 | 94,460 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 589.65 per share. | 02 Dec 2025 | 160 | 10,754 (0%) | 0% | 589.7 | 94,344 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 587.85 per share. | 02 Dec 2025 | 240 | 10,914 (0%) | 0% | 587.9 | 141,084 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 585.44 per share. | 02 Dec 2025 | 240 | 11,154 (0%) | 0% | 585.4 | 140,505 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 579.85 per share. | 02 Dec 2025 | 480 | 11,394 (0%) | 0% | 579.9 | 278,329 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 578.83 per share. | 02 Dec 2025 | 258 | 11,874 (0%) | 0% | 578.8 | 149,338 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 577.82 per share. | 02 Dec 2025 | 320 | 12,132 (0%) | 0% | 577.8 | 184,901 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 576.15 per share. | 02 Dec 2025 | 240 | 12,452 (0%) | 0% | 576.2 | 138,276 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 574.95 per share. | 02 Dec 2025 | 120 | 12,692 (0%) | 0% | 575.0 | 68,994 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 574.00 per share. | 02 Dec 2025 | 717 | 12,812 (0%) | 0% | 574.0 | 411,559 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 573.01 per share. | 02 Dec 2025 | 354 | 13,529 (0%) | 0% | 573.0 | 202,847 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 571.99 per share. | 02 Dec 2025 | 410 | 13,883 (0%) | 0% | 572.0 | 234,516 | Common Stock |
| Mardi C. Dier | EVP and CFO | Sale of securities on an exchange or to another person at price $ 570.39 per share. | 02 Dec 2025 | 320 | 14,293 (0%) | 0% | 570.4 | 182,524 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 550.97 per share. | 21 Nov 2025 | 894 | 11,096 (0%) | 0% | 551.0 | 492,567 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 563.20 per share. | 21 Nov 2025 | 40 | 10,112 (0%) | 0% | 563.2 | 22,528 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 560.62 per share. | 21 Nov 2025 | 80 | 10,152 (0%) | 0% | 560.6 | 44,850 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 559.60 per share. | 21 Nov 2025 | 200 | 10,232 (0%) | 0% | 559.6 | 111,920 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 556.04 per share. | 21 Nov 2025 | 120 | 10,432 (0%) | 0% | 556.0 | 66,725 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 553.22 per share. | 21 Nov 2025 | 40 | 10,552 (0%) | 0% | 553.2 | 22,129 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 552.38 per share. | 21 Nov 2025 | 200 | 10,592 (0%) | 0% | 552.4 | 110,477 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 564.56 per share. | 21 Nov 2025 | 80 | 10,032 (0%) | 0% | 564.6 | 45,165 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 549.35 per share. | 21 Nov 2025 | 40 | 10,792 (0%) | 0% | 549.4 | 21,974 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 548.71 per share. | 21 Nov 2025 | 120 | 10,832 (0%) | 0% | 548.7 | 65,845 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 547.27 per share. | 21 Nov 2025 | 144 | 10,952 (0%) | 0% | 547.3 | 78,807 | Common Stock |
| Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.36 per share. | 13 Nov 2025 | 2,500 | 23,697 (0%) | 0% | 7.4 | 18,400 | Common Stock |
| Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2025 | 6,000 | 4,000 | - | - | Stock Option (Right to Buy) | |
| Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2025 | 2,500 | 2,500 | - | - | Stock Option (Right to Buy) | |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 530.20 per share. | 13 Nov 2025 | 40 | 21,197 (0%) | 0% | 530.2 | 21,208 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 528.60 per share. | 13 Nov 2025 | 440 | 21,237 (0%) | 0% | 528.6 | 232,586 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 527.85 per share. | 13 Nov 2025 | 200 | 21,677 (0%) | 0% | 527.9 | 105,570 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 526.68 per share. | 13 Nov 2025 | 120 | 21,877 (0%) | 0% | 526.7 | 63,202 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 524.49 per share. | 13 Nov 2025 | 153 | 21,997 (0%) | 0% | 524.5 | 80,247 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 523.66 per share. | 13 Nov 2025 | 811 | 22,150 (0%) | 0% | 523.7 | 424,687 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 522.70 per share. | 13 Nov 2025 | 1,434 | 22,961 (0%) | 0% | 522.7 | 749,557 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 521.79 per share. | 13 Nov 2025 | 1,094 | 24,395 (0%) | 0% | 521.8 | 570,836 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 520.68 per share. | 13 Nov 2025 | 308 | 25,489 (0%) | 0% | 520.7 | 160,369 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 519.67 per share. | 13 Nov 2025 | 1,355 | 25,797 (0%) | 0% | 519.7 | 704,147 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 518.53 per share. | 13 Nov 2025 | 835 | 27,152 (0%) | 0% | 518.5 | 432,974 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 517.51 per share. | 13 Nov 2025 | 645 | 27,987 (0%) | 0% | 517.5 | 333,796 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 515.64 per share. | 13 Nov 2025 | 919 | 28,632 (0%) | 0% | 515.6 | 473,876 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 514.67 per share. | 13 Nov 2025 | 146 | 29,551 (0%) | 0% | 514.7 | 75,142 | Common Stock |
| Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.46 per share. | 13 Nov 2025 | 6,000 | 29,697 (0%) | 0% | 16.5 | 98,760 | Common Stock |
| Kenneth M. Bate | Director | 05 Nov 2025 | 5,470 | 8,097 (0%) | 0% | 9.5 | 51,692 | Common Stock | |
| Kenneth M. Bate | Director | 05 Nov 2025 | 1,105 | 0 | - | - | Stock Option (Right to Buy) | ||
| Kenneth M. Bate | Director | 05 Nov 2025 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Kenneth M. Bate | Director | 05 Nov 2025 | 5,470 | 0 | - | - | Stock Option (Right to Buy) | ||
| Kenneth M. Bate | Director | 05 Nov 2025 | 30 | 2,627 (0%) | 0% | 491.0 | 14,729 | Common Stock | |
| Kenneth M. Bate | Director | 05 Nov 2025 | 933 | 2,657 (0%) | 0% | 489.9 | 457,119 | Common Stock | |
| Kenneth M. Bate | Director | 05 Nov 2025 | 696 | 3,590 (0%) | 0% | 489.1 | 340,409 | Common Stock | |
| Kenneth M. Bate | Director | 05 Nov 2025 | 2,775 | 4,286 (0%) | 0% | 487.5 | 1,352,796 | Common Stock | |
| Kenneth M. Bate | Director | 05 Nov 2025 | 827 | 7,061 (0%) | 0% | 486.7 | 402,530 | Common Stock | |
| Kenneth M. Bate | Director | 05 Nov 2025 | 1,008 | 7,888 (0%) | 0% | 485.5 | 489,421 | Common Stock | |
| Kenneth M. Bate | Director | 05 Nov 2025 | 1,931 | 8,896 (0%) | 0% | 484.8 | 936,105 | Common Stock | |
| Kenneth M. Bate | Director | 05 Nov 2025 | 2,069 | 10,827 (0%) | 0% | 483.4 | 1,000,170 | Common Stock | |
| Kenneth M. Bate | Director | 05 Nov 2025 | 1,284 | 12,896 (0%) | 0% | 482.4 | 619,417 | Common Stock | |
| Kenneth M. Bate | Director | 05 Nov 2025 | 3,259 | 14,180 (0%) | 0% | 481.1 | 1,567,995 | Common Stock | |
| Kenneth M. Bate | Director | 05 Nov 2025 | 1,763 | 17,439 (0%) | 0% | 480.2 | 846,663 | Common Stock | |
| Kenneth M. Bate | Director | 05 Nov 2025 | 1,105 | 19,202 (0%) | 0% | 280.0 | 309,444 | Common Stock | |
| Kenneth M. Bate | Director | 05 Nov 2025 | 10,000 | 18,097 (0%) | 0% | 303.8 | 3,037,900 | Common Stock | |
| William John Sibold | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 445.63 per share. | 09 Sep 2025 | 7,279 | 102,474 (0%) | 0% | 445.6 | 3,243,741 | Common Stock |
| William John Sibold | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 400.03 per share. | 21 Aug 2025 | 6,485 | 110,884 (0%) | 0% | 400.0 | 2,594,225 | Common Stock |
| William John Sibold | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 401.00 per share. | 21 Aug 2025 | 1,131 | 109,753 (0%) | 0% | 401 | 453,531 | Common Stock |
| Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 358.66 per share. | 18 Aug 2025 | 458 | 10,019 (0%) | 0% | 358.7 | 164,266 | Common Stock |
| Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 376.62 per share. | 18 Aug 2025 | 42 | 9,173 (0%) | 0% | 376.6 | 15,818 | Common Stock |
| Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 375.75 per share. | 18 Aug 2025 | 190 | 9,215 (0%) | 0% | 375.8 | 71,393 | Common Stock |
| Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 374.13 per share. | 18 Aug 2025 | 68 | 9,405 (0%) | 0% | 374.1 | 25,441 | Common Stock |
| Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 372.44 per share. | 18 Aug 2025 | 252 | 9,473 (0%) | 0% | 372.4 | 93,855 | Common Stock |
| Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 371.35 per share. | 18 Aug 2025 | 84 | 9,725 (0%) | 0% | 371.3 | 31,193 | Common Stock |
| Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 370.06 per share. | 18 Aug 2025 | 84 | 9,809 (0%) | 0% | 370.1 | 31,085 | Common Stock |
| Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 369.64 per share. | 18 Aug 2025 | 126 | 9,893 (0%) | 0% | 369.6 | 46,575 | Common Stock |
| Kenneth M. Bate | Director | 15 Aug 2025 | 10,000 | 12,627 (0%) | 0% | 16.5 | 164,600 | Common Stock | |
| Kenneth M. Bate | Director | 15 Aug 2025 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Kenneth M. Bate | Director | 15 Aug 2025 | 896 | 2,627 (0%) | 0% | 368.6 | 330,226 | Common Stock | |
| Kenneth M. Bate | Director | 15 Aug 2025 | 1,104 | 3,523 (0%) | 0% | 367.6 | 405,865 | Common Stock | |
| Kenneth M. Bate | Director | 15 Aug 2025 | 600 | 4,627 (0%) | 0% | 366.1 | 219,683 | Common Stock | |
| Kenneth M. Bate | Director | 15 Aug 2025 | 2,567 | 5,227 (0%) | 0% | 365.3 | 937,793 | Common Stock | |
| Kenneth M. Bate | Director | 15 Aug 2025 | 2,516 | 7,794 (0%) | 0% | 364.2 | 916,428 | Common Stock | |
| Kenneth M. Bate | Director | 15 Aug 2025 | 2,317 | 10,310 (0%) | 0% | 363.4 | 842,014 | Common Stock | |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 13 Aug 2025 | 129,172 | 316,336 (2%) | 0% | 9.4 | 1,220,675 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2025 | 129,172 | 0 | - | - | Stock Option (Right to Buy) | |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 374.38 per share. | 13 Aug 2025 | 4,155 | 187,164 (1%) | 0% | 374.4 | 1,555,563 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 373.35 per share. | 13 Aug 2025 | 24,166 | 191,319 (1%) | 0% | 373.3 | 9,022,330 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 372.39 per share. | 13 Aug 2025 | 28,976 | 215,485 (1%) | 0% | 372.4 | 10,790,486 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 371.53 per share. | 13 Aug 2025 | 22,710 | 244,461 (1%) | 0% | 371.5 | 8,437,340 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 370.44 per share. | 13 Aug 2025 | 7,877 | 267,171 (1%) | 0% | 370.4 | 2,917,943 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 369.44 per share. | 13 Aug 2025 | 7,992 | 275,048 (1%) | 0% | 369.4 | 2,952,555 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 368.34 per share. | 13 Aug 2025 | 6,788 | 283,040 (1%) | 0% | 368.3 | 2,500,325 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 367.31 per share. | 13 Aug 2025 | 7,119 | 289,828 (1%) | 0% | 367.3 | 2,614,888 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 366.22 per share. | 13 Aug 2025 | 3,152 | 296,947 (1%) | 0% | 366.2 | 1,154,330 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 365.19 per share. | 13 Aug 2025 | 1,716 | 300,099 (1%) | 0% | 365.2 | 626,671 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 364.02 per share. | 13 Aug 2025 | 3,529 | 301,815 (1%) | 0% | 364.0 | 1,284,639 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 363.08 per share. | 13 Aug 2025 | 2,591 | 305,344 (1%) | 0% | 363.1 | 940,731 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 362.29 per share. | 13 Aug 2025 | 1,439 | 307,935 (1%) | 0% | 362.3 | 521,332 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 361.13 per share. | 13 Aug 2025 | 1,754 | 309,374 (2%) | 0% | 361.1 | 633,424 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 360.27 per share. | 13 Aug 2025 | 3,153 | 311,128 (2%) | 0% | 360.3 | 1,135,938 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 359.31 per share. | 13 Aug 2025 | 455 | 314,281 (2%) | 0% | 359.3 | 163,485 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 358.23 per share. | 13 Aug 2025 | 1,600 | 314,736 (2%) | 0% | 358.2 | 573,171 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 350.19 per share. | 11 Aug 2025 | 2,903 | 187,464 (1%) | 0% | 350.2 | 1,016,605 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 43,605 | 129,172 | - | - | Stock Option (Right to Buy) | |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 3,203 | 172,777 | - | - | Stock Option (Right to Buy) | |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 359.81 per share. | 11 Aug 2025 | 600 | 187,164 (1%) | 0% | 359.8 | 215,886 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 358.83 per share. | 11 Aug 2025 | 5,032 | 187,764 (1%) | 0% | 358.8 | 1,805,615 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 357.93 per share. | 11 Aug 2025 | 8,434 | 192,796 (1%) | 0% | 357.9 | 3,018,786 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 356.94 per share. | 11 Aug 2025 | 5,094 | 201,230 (1%) | 0% | 356.9 | 1,818,251 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 355.97 per share. | 11 Aug 2025 | 5,244 | 206,324 (1%) | 0% | 356.0 | 1,866,710 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 355.00 per share. | 11 Aug 2025 | 6,546 | 211,568 (1%) | 0% | 355.0 | 2,323,856 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 354.06 per share. | 11 Aug 2025 | 4,768 | 218,114 (1%) | 0% | 354.1 | 1,688,137 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 352.61 per share. | 11 Aug 2025 | 1,382 | 222,882 (1%) | 0% | 352.6 | 487,309 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 351.59 per share. | 11 Aug 2025 | 3,202 | 224,264 (1%) | 0% | 351.6 | 1,125,806 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 350.93 per share. | 11 Aug 2025 | 3,303 | 227,466 (1%) | 0% | 350.9 | 1,159,113 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 11 Aug 2025 | 43,605 | 230,769 (1%) | 0% | 9.4 | 412,067 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 351.04 per share. | 11 Aug 2025 | 300 | 187,164 (1%) | 0% | 351.0 | 105,312 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 11 Aug 2025 | 3,203 | 190,367 (1%) | 0% | 9.4 | 30,268 | Common Stock |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 43,263 | 0 | - | - | Stock Option (Right to Buy) | |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 3,200 | 43,263 | - | - | Stock Option (Right to Buy) | |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 359.71 per share. | 11 Aug 2025 | 700 | 461,044 (2%) | 0% | 359.7 | 251,798 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 358.81 per share. | 11 Aug 2025 | 6,541 | 461,744 (2%) | 0% | 358.8 | 2,346,983 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 357.85 per share. | 11 Aug 2025 | 6,715 | 468,285 (3%) | 0% | 357.9 | 2,402,982 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 356.88 per share. | 11 Aug 2025 | 4,864 | 475,000 (3%) | 0% | 356.9 | 1,735,861 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 355.95 per share. | 11 Aug 2025 | 5,752 | 479,864 (3%) | 0% | 356.0 | 2,047,436 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 354.97 per share. | 11 Aug 2025 | 6,479 | 485,616 (3%) | 0% | 355.0 | 2,299,873 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 354.04 per share. | 11 Aug 2025 | 4,587 | 492,095 (3%) | 0% | 354.0 | 1,623,997 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 352.45 per share. | 11 Aug 2025 | 1,175 | 496,682 (3%) | 0% | 352.5 | 414,130 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 351.60 per share. | 11 Aug 2025 | 2,870 | 497,857 (3%) | 0% | 351.6 | 1,009,091 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 350.87 per share. | 11 Aug 2025 | 3,580 | 500,727 (3%) | 0% | 350.9 | 1,256,127 | Common Stock |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 11 Aug 2025 | 43,263 | 504,307 (3%) | 0% | 9.4 | 408,835 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 351.02 per share. | 11 Aug 2025 | 220 | 461,044 (2%) | 0% | 351.0 | 77,225 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 350.18 per share. | 11 Aug 2025 | 2,980 | 461,264 (2%) | 0% | 350.2 | 1,043,528 | Common Stock |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 11 Aug 2025 | 3,200 | 464,244 (3%) | 0% | 9.5 | 30,240 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2025 | 1,400 | 175,980 | - | - | Stock Option (Right to Buy) | |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 350.00 per share. | 18 Jul 2025 | 1,000 | 461,044 (2%) | 0% | 350.0 | 350,005 | Common Stock |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 18 Jul 2025 | 1,000 | 462,044 (2%) | 0% | 9.5 | 9,450 | Common Stock |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2025 | 1,000 | 46,463 | - | - | Stock Option (Right to Buy) | |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 350.03 per share. | 18 Jul 2025 | 1,400 | 187,164 (1%) | 0% | 350.0 | 490,044 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 18 Jul 2025 | 1,400 | 188,564 (1%) | 0% | 9.5 | 13,230 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 16 Jul 2025 | 26,176 | 213,340 (1%) | 0% | 9.4 | 247,363 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 26,176 | 180,080 | - | - | Stock Option (Right to Buy) | |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 2,700 | 177,380 | - | - | Stock Option (Right to Buy) | |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 351.57 per share. | 16 Jul 2025 | 700 | 187,164 (1%) | 0% | 351.6 | 246,098 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 350.10 per share. | 16 Jul 2025 | 2,000 | 187,864 (1%) | 0% | 350.1 | 700,203 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 16 Jul 2025 | 2,700 | 189,864 (1%) | 0% | 9.5 | 25,515 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 356.62 per share. | 16 Jul 2025 | 1,200 | 187,164 (1%) | 0% | 356.6 | 427,941 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 355.61 per share. | 16 Jul 2025 | 5,784 | 188,364 (1%) | 0% | 355.6 | 2,056,860 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 354.65 per share. | 16 Jul 2025 | 6,851 | 194,148 (1%) | 0% | 354.6 | 2,429,697 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 353.82 per share. | 16 Jul 2025 | 2,319 | 200,999 (1%) | 0% | 353.8 | 820,507 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 352.67 per share. | 16 Jul 2025 | 2,110 | 203,318 (1%) | 0% | 352.7 | 744,133 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 351.38 per share. | 16 Jul 2025 | 2,371 | 205,428 (1%) | 0% | 351.4 | 833,131 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 350.17 per share. | 16 Jul 2025 | 5,541 | 207,799 (1%) | 0% | 350.2 | 1,940,275 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 350.19 per share. | 16 Jul 2025 | 6,000 | 481,488 (3%) | 0% | 350.2 | 2,101,142 | Common Stock |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 2,657 | 47,463 | - | - | Stock Option (Right to Buy) | |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2025 | 26,444 | 50,120 | - | - | Stock Option (Right to Buy) | |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 351.50 per share. | 16 Jul 2025 | 600 | 461,044 (2%) | 0% | 351.5 | 210,898 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 350.09 per share. | 16 Jul 2025 | 2,057 | 461,644 (2%) | 0% | 350.1 | 720,137 | Common Stock |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 16 Jul 2025 | 2,657 | 463,701 (3%) | 0% | 9.5 | 25,109 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 356.52 per share. | 16 Jul 2025 | 1,380 | 461,044 (2%) | 0% | 356.5 | 492,004 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 355.61 per share. | 16 Jul 2025 | 6,441 | 462,424 (2%) | 0% | 355.6 | 2,290,499 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 354.61 per share. | 16 Jul 2025 | 5,800 | 468,865 (3%) | 0% | 354.6 | 2,056,738 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 353.82 per share. | 16 Jul 2025 | 2,569 | 474,665 (3%) | 0% | 353.8 | 908,963 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 352.64 per share. | 16 Jul 2025 | 2,357 | 477,234 (3%) | 0% | 352.6 | 831,170 | Common Stock |
| Rebecca A. Taub | Director | Sale of securities on an exchange or to another person at price $ 351.37 per share. | 16 Jul 2025 | 1,897 | 479,591 (3%) | 0% | 351.4 | 666,546 | Common Stock |
| Rebecca A. Taub | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 16 Jul 2025 | 26,444 | 487,488 (3%) | 0% | 9.5 | 249,896 | Common Stock |
| Paul A. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 715 | 187,164 (1%) | 0% | 0 | Common Stock | |
| Paul A. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 1,290 | 1,290 | - | - | Stock Option (Right to Buy) | |
| Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 366 | 366 | - | - | Stock Option (Right to Buy) | |
| Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 203 | 1,097 (0%) | 0% | 0 | Common Stock | |
| Kenneth M. Bate | Director | 20 Jun 2025 | 715 | 2,627 (0%) | 0% | 0 | Common Stock | ||
| Kenneth M. Bate | Director | 20 Jun 2025 | 1,290 | 1,290 | - | - | Stock Option (Right to Buy) | ||
| Richard S. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 1,290 | 1,290 | - | - | Stock Option (Right to Buy) | |
| Richard S. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 715 | 21,197 (0%) | 0% | 0 | Common Stock | |
| James M. Daly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 1,290 | 1,290 | - | - | Stock Option (Right to Buy) | |
| James M. Daly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 715 | 2,627 (0%) | 0% | 0 | Common Stock | |
| David Soergel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 7,545 | 7,545 (0%) | 0% | 0 | Common Stock | |
| David Soergel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 12,839 | 12,839 | - | - | Stock Option (Right to Buy) | |
| Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.06 per share. | 10 Apr 2025 | 9,470 | 20,482 (0%) | 0% | 65.1 | 616,118 | Common Stock |
| Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2025 | 9,470 | 0 | - | - | Stock Option (Right to Buy) | |
| Frederick B. Craves | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.06 per share. | 12 Mar 2025 | 1,728 | 351,804 (2%) | 0% | 65.1 | 112,424 | Common Stock |
| Frederick B. Craves | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 7,742 | 0 | - | - | Stock Option (Right to Buy) | |
| Frederick B. Craves | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 6,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Frederick B. Craves | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 1,728 | 7,742 | - | - | Stock Option (Right to Buy) | |
| Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 330.23 per share. | 12 Mar 2025 | 75 | 350,076 (2%) | 0% | 330.2 | 24,767 | Common Stock |
| Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 329.86 per share. | 12 Mar 2025 | 967 | 350,151 (2%) | 0% | 329.9 | 318,975 | Common Stock |
| Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 328.68 per share. | 12 Mar 2025 | 400 | 351,118 (2%) | 0% | 328.7 | 131,472 | Common Stock |
| Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 327.63 per share. | 12 Mar 2025 | 1,000 | 351,518 (2%) | 0% | 327.6 | 327,627 | Common Stock |
| Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 325.63 per share. | 12 Mar 2025 | 800 | 352,518 (2%) | 0% | 325.6 | 260,501 | Common Stock |
| Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 324.69 per share. | 12 Mar 2025 | 900 | 353,318 (2%) | 0% | 324.7 | 292,218 | Common Stock |
| Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 323.47 per share. | 12 Mar 2025 | 1,649 | 354,218 (2%) | 0% | 323.5 | 533,394 | Common Stock |
| Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 322.45 per share. | 12 Mar 2025 | 1,951 | 355,867 (2%) | 0% | 322.5 | 629,100 | Common Stock |
| Frederick B. Craves | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.06 per share. | 12 Mar 2025 | 7,742 | 357,818 (2%) | 0% | 65.1 | 503,695 | Common Stock |
| Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 334.97 per share. | 12 Mar 2025 | 200 | 350,076 (2%) | 0% | 335.0 | 66,994 | Common Stock |
| Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 333.66 per share. | 12 Mar 2025 | 800 | 350,276 (2%) | 0% | 333.7 | 266,926 | Common Stock |
| Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 332.38 per share. | 12 Mar 2025 | 2,382 | 351,076 (2%) | 0% | 332.4 | 791,726 | Common Stock |
| Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 331.36 per share. | 12 Mar 2025 | 2,759 | 353,458 (2%) | 0% | 331.4 | 914,221 | Common Stock |
| Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 330.54 per share. | 12 Mar 2025 | 1,587 | 356,217 (2%) | 0% | 330.5 | 524,560 | Common Stock |
| Frederick B. Craves | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.06 per share. | 12 Mar 2025 | 6,000 | 357,804 (2%) | 0% | 111.1 | 666,360 | Common Stock |
| Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 894 | 894 (0%) | 0% | 0 | Common Stock | |
| Jacqualyn A. Fouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 1,579 | 1,579 | - | - | Stock Option (Right to Buy) | |
| Mardi C. Dier | SVP and CFO | Sale of securities on an exchange or to another person at price $ 323.04 per share. | 10 Mar 2025 | 258 | 10,440 (0%) | 0% | 323.0 | 83,344 | Common Stock |
| Rebecca A. Taub | Director, Pres., R&D, and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 4,382 | 461,044 (2%) | 0% | 0 | Common Stock | |
| Rebecca A. Taub | Director, Pres., R&D, and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 7,381 | 7,381 | - | - | Stock Option (Right to Buy) | |
| William John Sibold | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 22,009 | 22,009 | - | - | Stock Option (Right to Buy) | |
| William John Sibold | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 13,066 | 117,369 (0%) | 0% | 0 | Common Stock | |
| Mardi C. Dier | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 6,374 | 6,374 | - | - | Stock Option (Right to Buy) | |
| Mardi C. Dier | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 3,784 | 10,698 (0%) | 0% | 0 | Common Stock | |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Sale of securities on an exchange or to another person at price $ 344.76 per share. | 05 Mar 2025 | 1,412 | 3,728 (0%) | 0% | 344.8 | 486,797 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Sale of securities on an exchange or to another person at price $ 343.85 per share. | 05 Mar 2025 | 4,701 | 5,140 (0%) | 0% | 343.8 | 1,616,429 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Sale of securities on an exchange or to another person at price $ 342.90 per share. | 05 Mar 2025 | 1,077 | 9,841 (0%) | 0% | 342.9 | 369,300 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Sale of securities on an exchange or to another person at price $ 341.84 per share. | 05 Mar 2025 | 1,043 | 10,918 (0%) | 0% | 341.8 | 356,537 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Sale of securities on an exchange or to another person at price $ 340.75 per share. | 05 Mar 2025 | 1,657 | 11,961 (0%) | 0% | 340.8 | 564,627 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 1,157 | 1,157 | - | - | Stock Option (Right to Buy) | |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Sale of securities on an exchange or to another person at price $ 338.09 per share. | 05 Mar 2025 | 1,146 | 14,018 (0%) | 0% | 338.1 | 387,452 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Sale of securities on an exchange or to another person at price $ 336.78 per share. | 05 Mar 2025 | 1,777 | 15,164 (0%) | 0% | 336.8 | 598,457 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Sale of securities on an exchange or to another person at price $ 335.15 per share. | 05 Mar 2025 | 900 | 16,941 (0%) | 0% | 335.1 | 301,631 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.09 per share. | 05 Mar 2025 | 7,288 | 17,841 (0%) | 0% | 87.1 | 634,712 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.92 per share. | 05 Mar 2025 | 6,825 | 10,553 (0%) | 0% | 87.9 | 600,054 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Sale of securities on an exchange or to another person at price $ 339.68 per share. | 05 Mar 2025 | 400 | 13,618 (0%) | 0% | 339.7 | 135,874 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 7,288 | 3,062 | - | - | Stock Option (Right to Buy) | |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 6,825 | 4,375 | - | - | Stock Option (Right to Buy) | |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 2,061 | 5,789 (0%) | 0% | 0 | Common Stock | |
| Carole Huntsman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 5,703 | 5,703 | - | - | Stock Option (Right to Buy) | |
| Carole Huntsman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 3,386 | 11,990 (0%) | 0% | 0 | Common Stock | |
| Shannon T. Kelley | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 3,187 | 10,477 (0%) | 0% | 0 | Common Stock | |
| Shannon T. Kelley | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 5,368 | 5,368 | - | - | Stock Option (Right to Buy) | |
| Mardi C. Dier | SVP and CFO | Sale of securities on an exchange or to another person at price $ 323.54 per share. | 03 Mar 2025 | 774 | 6,914 (0%) | 0% | 323.5 | 250,417 | Common Stock |
| Mardi C. Dier | SVP and CFO | Sale of securities on an exchange or to another person at price $ 325.89 per share. | 03 Mar 2025 | 1,187 | 7,688 (0%) | 0% | 325.9 | 386,831 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 314.74 per share. | 03 Mar 2025 | 200 | 10,167 (0%) | 0% | 314.7 | 62,948 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 313.08 per share. | 03 Mar 2025 | 71 | 10,367 (0%) | 0% | 313.1 | 22,229 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 335.00 per share. | 03 Mar 2025 | 563 | 8,604 (0%) | 0% | 335 | 188,605 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 329.64 per share. | 03 Mar 2025 | 100 | 9,167 (0%) | 0% | 329.6 | 32,964 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 327.49 per share. | 03 Mar 2025 | 100 | 9,267 (0%) | 0% | 327.5 | 32,749 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 326.34 per share. | 03 Mar 2025 | 100 | 9,367 (0%) | 0% | 326.3 | 32,634 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 324.59 per share. | 03 Mar 2025 | 200 | 9,467 (0%) | 0% | 324.6 | 64,918 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 323.65 per share. | 03 Mar 2025 | 200 | 9,667 (0%) | 0% | 323.7 | 64,730 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 320.21 per share. | 03 Mar 2025 | 300 | 9,867 (0%) | 0% | 320.2 | 96,063 | Common Stock |
| Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 335.00 per share. | 03 Mar 2025 | 415 | 7,290 (0%) | 0% | 335 | 139,025 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Sale of securities on an exchange or to another person at price $ 340.99 per share. | 28 Feb 2025 | 1,052 | 3,903 (0%) | 0% | 341.0 | 358,717 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Sale of securities on an exchange or to another person at price $ 341.55 per share. | 28 Feb 2025 | 175 | 3,728 (0%) | 0% | 341.5 | 59,771 | Common Stock |
| Kenneth M. Bate | Director | 27 Feb 2025 | 8,545 | 12,529 (0%) | 0% | 355.1 | 3,034,150 | Common Stock | |
| Kenneth M. Bate | Director | 27 Feb 2025 | 6,000 | 7,912 (0%) | 0% | 111.1 | 666,360 | Common Stock | |
| Kenneth M. Bate | Director | 27 Feb 2025 | 9,470 | 17,382 (0%) | 0% | 65.1 | 616,118 | Common Stock | |
| Kenneth M. Bate | Director | 27 Feb 2025 | 4,530 | 21,912 (0%) | 0% | 9.5 | 42,809 | Common Stock | |
| Kenneth M. Bate | Director | 27 Feb 2025 | 100 | 21,812 (0%) | 0% | 351.0 | 35,101 | Common Stock | |
| Kenneth M. Bate | Director | 27 Feb 2025 | 500 | 21,312 (0%) | 0% | 352.0 | 175,995 | Common Stock | |
| Kenneth M. Bate | Director | 27 Feb 2025 | 238 | 21,074 (0%) | 0% | 353.8 | 84,213 | Common Stock | |
| Kenneth M. Bate | Director | 27 Feb 2025 | 2,038 | 7,700 (0%) | 0% | 357.3 | 728,109 | Common Stock | |
| Kenneth M. Bate | Director | 27 Feb 2025 | 2,791 | 9,738 (0%) | 0% | 356.5 | 995,016 | Common Stock | |
| Kenneth M. Bate | Director | 27 Feb 2025 | 2,024 | 2,128 (0%) | 0% | 359.2 | 727,042 | Common Stock | |
| Kenneth M. Bate | Director | 27 Feb 2025 | 3,548 | 4,152 (0%) | 0% | 358.3 | 1,271,359 | Common Stock | |
| Kenneth M. Bate | Director | 27 Feb 2025 | 4,530 | 5,470 | - | - | Stock Option (Right to Buy) | ||
| Kenneth M. Bate | Director | 27 Feb 2025 | 9,470 | 0 | - | - | Stock Option (Right to Buy) | ||
| Kenneth M. Bate | Director | 27 Feb 2025 | 6,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Kenneth M. Bate | Director | 27 Feb 2025 | 216 | 1,912 (0%) | 0% | 360.1 | 77,774 | Common Stock | |
| William John Sibold | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 50,000 | 104,303 (0%) | 0% | - | Common Stock | |
| William John Sibold | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 50,000 | 0 | - | - | Performance Restricted Stock Units | |
| James M. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 9,470 | 0 | - | - | Stock Option (Right to Buy) | |
| James M. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.06 per share. | 27 Feb 2025 | 9,470 | 11,382 (0%) | 0% | 65.1 | 616,118 | Common Stock |
| James M. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.06 per share. | 27 Feb 2025 | 6,000 | 17,382 (0%) | 0% | 111.1 | 666,360 | Common Stock |
| James M. Daly | Director | Sale of securities on an exchange or to another person at price $ 346.90 per share. | 27 Feb 2025 | 398 | 16,984 (0%) | 0% | 346.9 | 138,067 | Common Stock |
| James M. Daly | Director | Sale of securities on an exchange or to another person at price $ 347.39 per share. | 27 Feb 2025 | 14,302 | 2,682 (0%) | 0% | 347.4 | 4,968,372 | Common Stock |
| James M. Daly | Director | Sale of securities on an exchange or to another person at price $ 348.94 per share. | 27 Feb 2025 | 770 | 1,912 (0%) | 0% | 348.9 | 268,686 | Common Stock |
| James M. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 6,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 335.24 per share. | 24 Jan 2025 | 648 | 456,662 (2%) | 0% | 335.2 | 217,236 | Common Stock |
| William John Sibold | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 335.24 per share. | 24 Jan 2025 | 1,584 | 54,303 (0%) | 0% | 335.2 | 531,020 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Sale of securities on an exchange or to another person at price $ 335.24 per share. | 24 Jan 2025 | 103 | 4,955 (0%) | 0% | 335.2 | 34,530 | Common Stock |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 335.24 per share. | 24 Jan 2025 | 347 | 10,438 (0%) | 0% | 335.2 | 116,328 | Common Stock |
| Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 273.41 per share. | 17 Jan 2025 | 1,689 | 457,310 (2%) | 0% | 273.4 | 461,789 | Common Stock |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | Sale of securities on an exchange or to another person at price $ 273.41 per share. | 17 Jan 2025 | 442 | 5,058 (0%) | 0% | 273.4 | 120,847 | Common Stock |
| Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 273.41 per share. | 17 Jan 2025 | 277 | 7,705 (0%) | 0% | 273.4 | 75,735 | Common Stock |
| Craves Frederick B. | Director | 03 Dec 2024 | 3,080 | 11,520 (0%) | 0% | 315.2 | 970,852 | Common Stock | |
| Craves B. Frederick | Director | 03 Dec 2024 | 520 | 11,000 (0%) | 0% | 315.9 | 164,270 | Common Stock | |
| Craves B. Frederick | Director | 25 Nov 2024 | 1,200 | 14,600 (0%) | 0% | 350.7 | 420,858 | Common Stock | |
| B. Craves Frederick | Director | 25 Nov 2024 | 2,200 | 15,800 (0%) | 0% | 350.1 | 770,171 | Common Stock | |
| Carole Huntsman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 316.92 per share. | 21 Nov 2024 | 688 | 10,785 (0%) | 0% | 316.9 | 218,041 | Common Stock |
| Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.36 per share. | 07 Nov 2024 | 5,000 | 16,012 (0%) | 0% | 7.4 | 36,800 | Common Stock |
| Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 350.00 per share. | 07 Nov 2024 | 5,000 | 11,012 (0%) | 0% | 350 | 1,750,000 | Common Stock |
| Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.36 per share. | 01 Nov 2024 | 5,000 | 16,012 (0%) | 0% | 7.4 | 36,800 | Common Stock |
| Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 5,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 304.29 per share. | 01 Nov 2024 | 300 | 11,012 (0%) | 0% | 304.3 | 91,287 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 302.25 per share. | 01 Nov 2024 | 800 | 11,312 (0%) | 0% | 302.2 | 241,799 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 301.22 per share. | 01 Nov 2024 | 1,100 | 12,112 (0%) | 0% | 301.2 | 331,339 | Common Stock |
| Richard S. Levy | Director | Sale of securities on an exchange or to another person at price $ 300.10 per share. | 01 Nov 2024 | 2,800 | 13,212 (0%) | 0% | 300.1 | 840,278 | Common Stock |
| Frederick B. Craves | Director | 13 Sep 2024 | 15,000 | 360,076 (2%) | 0% | 0 | Common Stock | ||
| William John Sibold | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 243.83 per share. | 09 Sep 2024 | 6,363 | 55,887 (0%) | 0% | 243.8 | 1,551,490 | Common Stock |
| Shannon T. Kelley | General Counsel | 15 Aug 2024 | 5,215 | 7,982 (0%) | 0% | 0 | Common Stock | ||
| Shannon T. Kelley | General Counsel | 15 Aug 2024 | 7,820 | 7,820 | - | - | Stock Option (Right to Buy) | ||
| Paul A. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 714 | 186,449 (1%) | 0% | 0 | Common Stock | |
| Paul A. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 1,105 | 1,105 | - | - | Stock Option (Right to Buy) | |
| Frederick B. Craves | Director | 25 Jun 2024 | 714 | 375,076 (2%) | 0% | 0 | Common Stock | ||
| Frederick B. Craves | Director | 25 Jun 2024 | 1,105 | 1,105 | - | - | Stock Option (Right to Buy) | ||
| Kenneth M. Bate | Director | 25 Jun 2024 | 714 | 1,912 (0%) | 0% | 0 | Common Stock | ||
| Kenneth M. Bate | Director | 25 Jun 2024 | 1,105 | 1,105 | - | - | Stock Option (Right to Buy) | ||
| Richard S. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 714 | 11,012 (0%) | 0% | 0 | Common Stock | |
| Richard S. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 1,105 | 1,105 | - | - | Stock Option (Right to Buy) | |
| James M. Daly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 1,105 | 1,105 | - | - | Stock Option (Right to Buy) | |
| James M. Daly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 714 | 1,912 (0%) | 0% | 0 | Common Stock | |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | 14 Jun 2024 | 1,900 | 10,350 | - | - | Stock Option (Right to Buy) | ||
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | 14 Jun 2024 | 1,900 | 7,400 (0%) | 0% | 87.1 | 165,471 | Common Stock | |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | 14 Jun 2024 | 1,900 | 5,500 (0%) | 0% | 280 | 532,000 | Common Stock | |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | 12 Jun 2024 | 2,000 | 15,200 | - | - | Stock Option (Right to Buy) | ||
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | 12 Jun 2024 | 2,000 | 5,500 (0%) | 0% | 285 | 570,000 | Common Stock | |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | 12 Jun 2024 | 2,000 | 7,500 (0%) | 0% | 87.9 | 175,840 | Common Stock | |
| Frederick B. Craves | Director | 11 Jun 2024 | 39,000 | 374,362 (2%) | 0% | 0 | Common Stock | ||
| Frederick B. Craves | Director | 11 Jun 2024 | 45,852 | 11,210 (0%) | 0% | 0 | Common Stock | ||
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | 21 May 2024 | 1,036 | 5,500 (0%) | 0% | 231.3 | 239,668 | Common Stock | |
| Frederick B. Craves | Director | 14 May 2024 | 1,100 | 414,462 (2%) | 0% | 217.9 | 239,641 | Common Stock | |
| Frederick B. Craves | Director | 14 May 2024 | 8,827 | 427,024 (2%) | 0% | 211.0 | 1,862,432 | Common Stock | |
| Frederick B. Craves | Director | 14 May 2024 | 12,489 | 435,851 (2%) | 0% | 105.1 | 1,312,344 | Common Stock | |
| Frederick B. Craves | Director | 14 May 2024 | 10,000 | 423,362 (2%) | 0% | 100.5 | 1,004,500 | Common Stock | |
| Frederick B. Craves | Director | 14 May 2024 | 12,489 | 0 | - | - | Stock Option (right to buy) | ||
| Frederick B. Craves | Director | 14 May 2024 | 10,000 | 0 | - | - | Stock Option (right to buy) | ||
| Frederick B. Craves | Director | 14 May 2024 | 100 | 413,362 (2%) | 0% | 219.9 | 21,990 | Common Stock | |
| Frederick B. Craves | Director | 14 May 2024 | 1,000 | 413,462 (2%) | 0% | 219.0 | 218,995 | Common Stock | |
| Frederick B. Craves | Director | 14 May 2024 | 721 | 415,562 (2%) | 0% | 217.0 | 156,445 | Common Stock | |
| Frederick B. Craves | Director | 14 May 2024 | 375 | 416,283 (2%) | 0% | 216.1 | 81,031 | Common Stock | |
| Frederick B. Craves | Director | 14 May 2024 | 1,804 | 416,658 (2%) | 0% | 214.7 | 387,285 | Common Stock | |
| Frederick B. Craves | Director | 14 May 2024 | 2,190 | 418,462 (2%) | 0% | 213.9 | 468,342 | Common Stock | |
| Frederick B. Craves | Director | 14 May 2024 | 1,363 | 420,652 (2%) | 0% | 212.9 | 290,116 | Common Stock | |
| Frederick B. Craves | Director | 14 May 2024 | 5,009 | 422,015 (2%) | 0% | 211.8 | 1,061,127 | Common Stock | |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 244.12 per share. | 08 Apr 2024 | 3,730 | 206,834 (1%) | 0% | 244.1 | 910,566 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 242.95 per share. | 08 Apr 2024 | 1,441 | 210,564 (1%) | 0% | 243.0 | 350,094 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 08 Apr 2024 | 26,270 | 212,005 (1%) | 0% | 9.5 | 248,252 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 248.59 per share. | 08 Apr 2024 | 4,866 | 185,735 (1%) | 0% | 248.6 | 1,209,642 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 247.76 per share. | 08 Apr 2024 | 3,464 | 190,601 (1%) | 0% | 247.8 | 858,241 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 246.96 per share. | 08 Apr 2024 | 5,028 | 194,065 (1%) | 0% | 247.0 | 1,241,710 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 245.71 per share. | 08 Apr 2024 | 2,078 | 199,093 (1%) | 0% | 245.7 | 510,591 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 26,270 | 206,256 | - | - | Stock Option (Right to Buy) | |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 244.86 per share. | 08 Apr 2024 | 5,663 | 201,171 (1%) | 0% | 244.9 | 1,386,646 | Common Stock |
| Rebecca A. Taub | Director, Pres., R&D, and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 08 Apr 2024 | 2,676 | 461,675 (2%) | 0% | 9.4 | 25,288 | Common Stock |
| Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 244.79 per share. | 08 Apr 2024 | 945 | 460,506 (2%) | 0% | 244.8 | 231,325 | Common Stock |
| Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 245.69 per share. | 08 Apr 2024 | 300 | 460,206 (2%) | 0% | 245.7 | 73,706 | Common Stock |
| Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 246.98 per share. | 08 Apr 2024 | 600 | 459,606 (2%) | 0% | 247.0 | 148,186 | Common Stock |
| Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 247.76 per share. | 08 Apr 2024 | 407 | 459,199 (2%) | 0% | 247.8 | 100,838 | Common Stock |
| Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 248.58 per share. | 08 Apr 2024 | 200 | 458,999 (2%) | 0% | 248.6 | 49,716 | Common Stock |
| Rebecca A. Taub | Director, Pres., R&D, and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 2,676 | 76,564 | - | - | Stock Option (Right to Buy) | |
| Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 243.25 per share. | 08 Apr 2024 | 224 | 461,451 (2%) | 0% | 243.2 | 54,487 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 03 Apr 2024 | 27,613 | 213,348 (1%) | 0% | 9.5 | 260,943 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 27,613 | 232,526 | - | - | Stock Option (Right to Buy) | |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 18,710 | 260,139 | - | - | Stock Option (Right to Buy) | |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 27,407 | 278,849 | - | - | Stock Option (Right to Buy) | |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 245.92 per share. | 03 Apr 2024 | 444 | 185,735 (1%) | 0% | 245.9 | 109,189 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 245.35 per share. | 03 Apr 2024 | 5,228 | 186,179 (1%) | 0% | 245.3 | 1,282,669 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 244.22 per share. | 03 Apr 2024 | 3,966 | 191,407 (1%) | 0% | 244.2 | 968,588 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 243.20 per share. | 03 Apr 2024 | 9,264 | 195,373 (1%) | 0% | 243.2 | 2,253,016 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 242.42 per share. | 03 Apr 2024 | 6,679 | 204,637 (1%) | 0% | 242.4 | 1,619,098 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 241.15 per share. | 03 Apr 2024 | 612 | 211,316 (1%) | 0% | 241.1 | 147,582 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 240.10 per share. | 03 Apr 2024 | 1,420 | 211,928 (1%) | 0% | 240.1 | 340,939 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 248.42 per share. | 03 Apr 2024 | 200 | 185,735 (1%) | 0% | 248.4 | 49,685 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 247.14 per share. | 03 Apr 2024 | 737 | 185,935 (1%) | 0% | 247.1 | 182,141 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 246.13 per share. | 03 Apr 2024 | 1,558 | 186,672 (1%) | 0% | 246.1 | 383,471 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 245.14 per share. | 03 Apr 2024 | 2,549 | 188,230 (1%) | 0% | 245.1 | 624,857 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 244.31 per share. | 03 Apr 2024 | 627 | 190,779 (1%) | 0% | 244.3 | 153,185 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 243.00 per share. | 03 Apr 2024 | 1,467 | 191,406 (1%) | 0% | 243.0 | 356,482 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 242.25 per share. | 03 Apr 2024 | 5,299 | 192,873 (1%) | 0% | 242.2 | 1,283,679 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 241.07 per share. | 03 Apr 2024 | 6,273 | 198,172 (1%) | 0% | 241.1 | 1,512,222 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 03 Apr 2024 | 18,710 | 204,445 (1%) | 0% | 9.5 | 176,810 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 246.31 per share. | 03 Apr 2024 | 1,821 | 185,735 (1%) | 0% | 246.3 | 448,530 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 245.34 per share. | 03 Apr 2024 | 18,806 | 187,556 (1%) | 0% | 245.3 | 4,613,823 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 244.58 per share. | 03 Apr 2024 | 4,301 | 206,362 (1%) | 0% | 244.6 | 1,051,959 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 243.64 per share. | 03 Apr 2024 | 2,294 | 210,663 (1%) | 0% | 243.6 | 558,921 | Common Stock |
| Paul A. Friedman | Director | Sale of securities on an exchange or to another person at price $ 242.00 per share. | 03 Apr 2024 | 185 | 212,957 (1%) | 0% | 242 | 44,770 | Common Stock |
| Paul A. Friedman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 03 Apr 2024 | 27,407 | 213,142 (1%) | 0% | 9.4 | 258,996 | Common Stock |
| Rebecca A. Taub | Director, Pres., R&D, and CMO | Sale of securities on an exchange or to another person at price $ 242.00 per share. | 03 Apr 2024 | 135 | 486,709 (3%) | 0% | 242 | 32,670 | Common Stock |
| Rebecca A. Taub | Director, Pres., R&D, and CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 27,506 | 79,240 | - | - | Stock Option (Right to Buy) |